Company / Gross Profit
BioLife Solutions, Inc. Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$62.1M
FY2025
5-year range
$41.3M / $62.1M
FY2021-FY2025
Trend
+24.0%
vs FY2024
Sector context
#91 of 95
Health Care
What the data says
Among 95 Health Care companies, BioLife Solutions, Inc. is in the bottom 4% for gross profit. Gross Profit has increased for 5 consecutive years, from $5M in FY2016 to $62M in FY2025.
Based on SEC 10-K filings.
$62M in FY2025.
Improved from $41M to $62M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 95This company $62.1M Sector average $1.9B
▼
-96.7% below sector average
Key checks
Key Insights
- In FY2025, gross profit increased 24.0% year-over-year.
- Ranks #91 out of 95 companies in the Health Care sector.
- Lowest gross profit in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $62.1M | +24.0% |
| FY2024 | $50.1M | +21.2% |
| FY2023 | $41.3M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $13.5M | +100.5% |
| FY2017 | $6.7M | +41.2% |
| FY2016 | $4.8M | +25.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026